Vorapaxar

Vorapaxar (brand name Zontivity, formerly known as SCH 530348) is a thrombin receptor (protease-activated receptor, PAR-1) antagonist based on the natural product himbacine, discovered by Schering-Plough and developed by Merck & Co.[2] Contents 1 Medical uses 2 Contraindications 3 Drug interactions 4 Dose adjustment 5 Mechanism of action 6 Storage 7 History 8 References 9 External links Medical uses Vorapaxar is used for persons with a history of myocardial infarcti... [wikipedia]